Catalyst Clinical Research, a provider of specialized clinical development solutions, completed the acquisition of Genpro Research, a clinical research organization. Financial terms were not disclosed. "We are hugely enthusiastic about the addition of Genpro to our family. We share the opportunity to expand our global footprint, broaden and deepen our services, and to use the AI platform to create value for ourselves and customers in a range of labor-intensive document creation processes. In addition, our approach to prioritizing culture and treating our teams like family are similar and will act as a critical foundation for our combined company as we move forward," Nick Dyer, Catalyst CEO.